Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Heading


ID#:18346
Description:Caption:
Photographed on October 4, 2007 this image depicts Dr. John M. Dye, Jr., U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Viral Immunology branch chief, as he was working in the laboratory at the USAMRIID headquarters in Frederick, Maryland. Dr. Dye is leading a team that is conducting a study with nonhuman primates involving the experimental drug ZMapp, an experimental treatment for Ebola patients.
Additional Information:
USAMRIID scientists here have worked for years on earlier versions of the Mapp Biopharmaceuticals cocktail of three different monoclonal antibodies. The drug is in Phase 1 clinical trials, but has not yet completed testing in people, for safety or effectiveness.

“From on-site laboratory support in Liberia, to training of key personnel, to accelerated research efforts on diagnostic, vaccine and treatment approaches, the USAMRIID is playing a significant role in assisting the Ebola Virus Disease outbreak response in West Africa.” See more about USAMRIID support for the Ebola Virus Disease outbreak by way of the link below.

High Resolution: Click here for hi-resolution image (6.52 MB)
Content Providers(s):U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
Creation Date:2007
Photo Credit:U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
Links:WWW.ARMY.MIL - USAMRIID supports Ebola Virus Disease outbreak response in West Africa
Flickr - USAMRIID: U.S. Army Medical Research Institute of Infectious Diseases
Categories:
CDC Organization
Skip Navigation Links.

MeSH
Skip Navigation Links.
Copyright Restrictions:None - This image is in the public domain and thus free of any copyright restrictions. As a matter of courtesy we request that the content provider be credited and notified in any public or private usage of this image.

TOP